anti-MEK2, mAb (1A1)

CHF 322.00
In stock
YIF-LF-MA0193100 µlCHF 322.00
More Information
Product Details
Synonyms MEK2; MEK 2; MAP2K2; MAPKK 2; EC=; MAPK/ERK Kinase 2; MAP Kinase Kinase 2; ERK Activator Kinase 2; Dual Specificity Mitogen-activated Protein Kinase Kinase 2
Product Type Monoclonal Antibody
Clone 1A1
Isotype Mouse IgG1 κ
Immunogen/Antigen Recombinant human His-MEK2 protein purified from E. coli.
Application Western Blot (1:2,000)
Immunoprecipitation (2 μl)
Crossreactivity Human
Purity Detail Ammonium sulfate precipitation.
Formulation Liquid. HEPES with 0.15M NaCl, 0.01% BSA, 0.03% sodium azide, and 50% glycerol.
Other Product Data Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
Declaration Manufactured by AbFrontier
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Product Specification Sheet
Datasheet Download PDF
The MAP Kinase pathway is a key signaling mechanism that regulates many cellular functions such as cell growth, proliferation, differentiation, development, transformation and apoptosis. The basic arrangement includes a G-protein, a MAPK kinase kinase (MAPKKK) that phosphorylates and activates a MAPK kinase (MAPKK), which in turn phosphorylates MAPK. The ERK (extracellular-signal regulated kinase) cascade is a central MAPK pathway which contains Ras as a G protein, Raf as a MAPKKK, MEK1 (MAPK/ERK kinase1) and MEK2 (MAPK/ERK kinase2) as MAPKK, and ERKs as MAPK. MEK1 and MEK2 are 80% identical to each other, and are essentially identical in most of their kinase domain. MEK1 and MEK2 phosphorylate ERKs equally well, both in vivo and in vitro. MEK1 (45 KDa) and MEK2 (46 KDa) are composed of a catalytic kinase domain, which is surrounded by a regulatory N-terminal domain ( 80 amino acids) and a shorter C-terminal region ( 30 amino acids). Unlike the kinase domains, the N-termini and the characteristic Pro-rich inserts are quite divergent between the two MEKs (40% identity). MEKs are activated by phosphorylation of two Ser residues in their activation loop (Ser218 and Ser222 in MEK1) located within a Ser–Xaa–Ala–Xaa–Ser/Thr motif, typical to all MAPKKs. Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases
Product References
1) Shaul Y.D. and Seger R., (2007) Biochim Biophys Acta. 1773:1213-1226. (General)
2) Ravingerova T. et al., (2003) Mol Cell Biochem. 247:127-138. (General)
3) Kolch W., (2000) Biochem J. 351 Pt2:289-305. (General)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.